← 產業報告目錄

Medical Coatings Market by Coating Type (Active, Passive), By Material (Polymers, Metals), By Application (Medical Devices, Medical Implants, Medical Equipment & Tools), By Region – Global Forecast to 2030

出版商 MarketsandMarkets產業別 Chemicals & Materials出版日期 2025-07-22頁數 290報告編號 CH3023

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The medical coating market is expected to reach USD 15,813.6 million by 2030, up from USD 9,983.0 million in 2025, growing at a CAGR of 9.6%. The rising demand for medical devices in the healthcare sector significantly drives the growth of the medical coating market, as coatings continue to evolve and become crucial for the safety, performance, and durability of devices. An aging population and a higher prevalence of chronic diseases create a greater need for coated devices such as implants, catheters, and surgical instruments, thereby supporting market growth and fostering innovation. “Based on application, medical devices will be the largest application in the medical coating market during the forecast period, in terms of value.” The medical devices application segment is projected to be the largest in the medical coating market by value during the forecast period due to the widespread and increasing use of coated devices across all organizations and healthcare settings. The adoption of various coated medical devices is mainly driven by the rising rates of chronic diseases, the growing aging global population, and advancements in minimally invasive surgical procedures, all of which require performance-enhanced, safer, and easier-to-use medical devices. Medical coatings are vital for many devices, including catheters, stents, guidewires, orthopedic implants, and surgical instruments, as they offer superior lubricity, biocompatibility, and antimicrobial properties. These coatings reduce friction, minimizing tissue trauma, lower infection risks, and improve device performance and shelf-life. Additionally, the rise in hospital-acquired infections has made antimicrobial and anti-thrombogenic coatings essential for patient safety and meeting strict regulatory standards. Innovations in medical technology, such as imaging systems and precision instruments, have significantly increased the demand for high-performance medical coatings to achieve more accurate and less traumatic surgical outcomes. Therefore, the medical devices segment is expected to continue its growth. “Based on coating type, active coating will be the fastest in the medical coating market during the forecast period, in terms of value.” Active coatings are the fastest-growing type of coating by value in the medical coating market during the forecast period, due to their specialized therapeutic capabilities compared to passive coatings and the increasing demand for innovative solutions to improve patient safety and clinical outcomes. While passive coatings only provide surface protection during use (such as protection and lubrication), active coatings are engineered to release drugs, antimicrobial agents, or bioactive molecules at the application site. This delivery method is essential for high-risk medical devices (like stents, catheters, and orthopedic implants) where infection, thrombosis, and inflammation threaten successful patient management. The rise in hospital-acquired infections and the worldwide increase in chronic diseases and comorbidities expose chronic patients to higher infection risks, as post-surgical complications—such as PMN-mediated inflammation and infections—lead to extended risks and costs. Therefore, hospitals and healthcare providers are seeking more effective coatings that reduce the risk of hospital-acquired infections and promote faster recovery. “Based on region, North America accounts for the largest share in the medical coating market, in terms of value.” North America is the largest and fastest-growing region in the medical coating market, with value growth driven by advanced healthcare delivery systems, an increase in procedures performed, and a strong commitment to the continuous development of medical devices. North America, especially the United States, hosts many top medical device manufacturers and research institutions that are innovating the next generation of coatings for applications such as cardiovascular stents, orthopedic implants, catheters, and surgical instruments. Additionally, the rising demand for medical coatings in North America is linked to a growing and aging population with increasing rates of chronic diseases, as well as a heightened focus on infection control and patient safety, which demand sophisticated, biocompatible, and antimicrobial coatings. During the process of determining and verifying the market size for various segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees is as follows: • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30% • By Designation: Directors- 35%, Managers - 25%, and Others - 40% • By Region: North America - 22%, Europe - 22%, Asia Pacific - 45%, RoW – 11% The key players in this market are Hydromer (US), DSM-Firmenich (Netherlands), Surmodics (US), Biocoat Incorporated (US), AST Products Inc (US), Covalon Technologies (Canada), Freudenberg Medical (US), Harland Medical Systems, Inc (US), Merit Medical Systems (US), Applied Medical Coatings (US), PPG Industries, Inc. (US) and The Sherwin-Williams Company (US). Research Coverage This report breaks down the medical coating market by coating type, material, substrate, application, and region, and provides estimates for the total market value across different regions. A thorough analysis of major industry players has been carried out to offer insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions related to the medical coating market. Key benefits of buying this report This research report covers different levels of analysis, including industry examination (industry trends), market ranking analysis of leading players, and company profiles. Together, these provide a comprehensive view of the competitive landscape, emerging and high-growth segments of the medical coating market, high-growth regions, and market drivers, restraints, opportunities, and challenges. The report provides insights on the following: • Analysis of key drivers (increasing demand for minimally invasive surgical procedures, growing geriatric population and prevalence of chronic diseases), restraints (stringent regulatory requirements, high costs and technical challenges), opportunities (development of smart and multifunctional coatings, expansion in emerging markets) and challenges (technical limitations in coating durability and adhesion, intellectual property and supply chain issues). • Market Penetration: Comprehensive information on the medical coating market offered by top players in the global medical coating market • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the medical coating market • Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for medical coating market across regions • Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global medical coating market • Competitive Assessment: In-depth assessment of market share, strategies, products, and manufacturing capabilities of leading players in the medical coating market
目錄 Table of Contents
1 INTRODUCTION 25 1.1 STUDY OBJECTIVES 25 1.2 MARKET DEFINITION 25 1.3 STUDY SCOPE 26 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 26 1.3.2 INCLUSIONS & EXCLUSIONS OF STUDY 27 1.4 CURRENCY CONSIDERED 27 1.5 UNITS CONSIDERED 27 1.6 STAKEHOLDERS 28 1.7 SUMMARY OF CHANGES 28 2 RESEARCH METHODOLOGY 29 2.1 RESEARCH DATA 29 2.1.1 SECONDARY DATA 30 2.1.1.1 List of key secondary sources 30 2.1.1.2 Key data from secondary sources 30 2.1.2 PRIMARY DATA 31 2.1.2.1 Key data from primary sources 31 2.1.2.2 List of primary interview participants—demand and supply sides 31 2.1.2.3 Key industry insights 32 2.1.2.4 Breakdown of interviews with experts 32 2.2 MARKET SIZE ESTIMATION 32 2.2.1 BOTTOM-UP APPROACH 33 2.2.2 TOP-DOWN APPROACH 33 2.3 FORECAST NUMBER CALCULATION 34 2.4 DATA TRIANGULATION 35 2.5 FACTOR ANALYSIS 36 2.6 ASSUMPTIONS 36 2.7 LIMITATIONS & RISKS 37 3 EXECUTIVE SUMMARY 38 4 PREMIUM INSIGHTS 41 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL COATING MARKET 41 4.2 MEDICAL COATING MARKET, BY COATING TYPE 41 4.3 MEDICAL COATING MARKET, BY MATERIAL 42 4.4 MEDICAL COATING MARKET, BY SUBSTRATE 42 4.5 MEDICAL COATING MARKET, BY APPLICATION 43 4.6 MEDICAL COATING MARKET, BY KEY COUNTRY 43 5 MARKET OVERVIEW 44 5.1 INTRODUCTION 44 5.2 MARKET DYNAMICS 44 5.2.1 DRIVERS 45 5.2.1.1 Increasing prevalence of chronic diseases and aging population 45 5.2.1.2 Rise in hospital-acquired infections 45 5.2.1.3 Growth in minimally invasive surgeries and medical device usage 45 5.2.2 RESTRAINTS 46 5.2.2.1 Low shelf life and durability issues 46 5.2.2.2 Raw material price volatility and high costs 46 5.2.2.3 Strict government regulations and compliance challenges 46 5.2.3 OPPORTUNITIES 47 5.2.3.1 Rise in demand for antimicrobial and drug-eluting coatings 47 5.2.3.2 Technological advancements and nanotechnology 47 5.2.4 CHALLENGES 48 5.2.4.1 Biocompatibility and durability concerns 48 5.2.4.2 Complex application and quality control 48 6 INDUSTRY TRENDS 49 6.1 VALUE CHAIN ANALYSIS 49 6.1.1 RAW MATERIAL SUPPLIERS 49 6.1.2 MANUFACTURERS 49 6.1.3 DISTRIBUTORS 50 6.1.4 END USERS 50 6.2 ECOSYSTEM ANALYSIS 50 6.3 PORTER’S FIVE FORCES ANALYSIS 51 6.3.1 THREAT OF NEW ENTRANTS 52 6.3.2 THREAT OF SUBSTITUTES 52 6.3.3 BARGAINING POWER OF SUPPLIERS 53 6.3.4 BARGAINING POWER OF BUYERS 53 6.3.5 INTENSITY OF COMPETITIVE RIVALRY 53 6.4 KEY STAKEHOLDERS AND BUYING CRITERIA 54 6.4.1 KEY STAKEHOLDERS IN BUYING PROCESS 54 6.4.2 QUALITY 54 6.4.3 SERVICE 54 6.4.4 BUYING CRITERIA 55 6.5 TRADE ANALYSIS 56 6.5.1 EXPORT SCENARIO (HS CODE 9018) 56 6.5.2 IMPORT SCENARIO (HS CODE 9018) 57 6.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 58 6.7 TECHNOLOGY ANALYSIS 59 6.7.1 KEY TECHNOLOGIES 59 6.7.1.1 Plasma spraying 59 6.7.1.2 Chemical vapor deposition 59 6.7.1.3 Microblasting & laser treatments 59 6.7.2 COMPLEMENTARY TECHNOLOGIES 60 6.7.2.1 Nanotechnology integration 60 6.7.2.2 Advanced material formulation 60 6.8 MACROECONOMIC INDICATORS 60 6.8.1 GDP TRENDS AND FORECASTS 60 6.9 PRICING ANALYSIS 62 6.9.1 AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024 62 6.9.2 AVERAGE SELLING PRICE TREND, BY COATING TYPE, 2022–2024 63 6.10 REGULATORY LANDSCAPE 64 6.10.1 NORTH AMERICA 64 6.10.2 ASIA PACIFIC 65 6.10.3 EUROPE 65 6.10.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66 6.11 IMPACT OF AI/GEN AI 67 6.12 KEY CONFERENCES AND EVENTS, 2025–2026 68 6.13 CASE STUDY ANALYSIS 68 6.13.1 ANTIMICROBIAL COATING FOR IMPLANTABLE PACEMAKER DEVICE 68 6.13.2 INTRICOAT FOR MEDICAL ROBOTICS PROJECT 69 6.13.3 SLIPS COATING TO PREVENT BIOFILM FORMATION ON MEDICAL IMPLANTS 69 6.14 INVESTMENT AND FUNDING SCENARIO 70 6.15 PATENT ANALYSIS 70 6.15.1 INTRODUCTION 70 6.15.2 LEGAL STATUS OF PATENTS 72 6.15.3 JURISDICTION ANALYSIS 72 6.16 IMPACT OF 2025 US TARIFF – OVERVIEW 73 6.16.1 INTRODUCTION 73 6.17 KEY TARIFF RATES 73 6.18 PRICE IMPACT ANALYSIS 74 6.19 IMPACT ON COUNTRY/REGION 74 6.19.1 US 74 6.19.2 EUROPE 75 6.19.3 ASIA PACIFIC 76 6.20 IMPACT ON END-USE INDUSTRIES 77   7 MEDICAL COATINGS MARKET, BY COATING TYPE 78 7.1 INTRODUCTION 79 7.2 ACTIVE 81 7.2.1 ANTIMICROBIAL 81 7.2.1.1 Used to prevent microbial infection on medical devices 81 7.2.2 OTHERS 81 7.3 PASSIVE 82 7.3.1 HYDROPHILIC/LUBRICIOUS HYDROPHILIC 82 7.3.1.1 Growing awareness of minimally invasive surgical techniques to boost demand 82 7.3.2 HYDROPHOBIC 83 7.3.2.1 High water resistance to drive market growth 83 8 MEDICAL COATINGS MARKET, BY MATERIAL TYPE 84 8.1 INTRODUCTION 85 8.2 POLYMERS 88 8.2.1 FLUOROPOLYMERS 88 8.2.1.1 PTFE 88 8.2.1.1.1 Minimal friction and strong resistance to heat and chemicals to boost adoption 88 8.2.1.2 PVDF 89 8.2.1.2.1 Exceptionally robust and resistant to chemicals 89 8.2.1.3 Others 89 8.2.2 PARYLENE 89 8.2.2.1 Frictional coefficient comparable to PTFE – key segment driver 89 8.2.3 SILICONES 89 8.2.3.1 Biocompatibility fuels widespread adoption in medical applications 89 8.2.4 OTHERS 90 8.3 METALS 90 8.3.1 SILVER 90 8.3.1.1 Antimicrobial properties boost application 90 8.3.2 TITANIUM 91 8.3.2.1 Commonly employed in implant applications due to excellent biocompatibility 91 8.3.3 OTHERS 91 8.4 OTHERS 91 9 MEDICAL COATINGS MARKET, BY SUBSTRATE 92 9.1 INTRODUCTION 93 9.2 METALS 95 9.2.1 METALS IN IMPLANTED MEDICAL DEVICES: DRIVING BIOCOMPATIBILITY AND MARKET GROWTH 95   9.3 CERAMICS 95 9.3.1 WIDELY USED IN DENTAL IMPLANT APPLICATIONS 95 9.4 POLYMERS 96 9.4.1 FLUOROPOLYMERS 96 9.4.1.1 PTFE’s unparalleled lubricity boosts advanced medical device performance 96 9.4.2 SILICONE 96 9.4.2.1 Superior compatibility with human tissue and bodily fluids 96 9.4.3 OTHER POLYMERS 97 9.5 COMPOSITES 97 9.5.1 LIGHT WEIGHT PROPERTY ENHANCES PROSTHETIC MOBILITY 97 9.6 GLASS 97 9.6.1 OFFERS BIOCOMPATIBILITY FOR SAFE AND DURABLE MEDICAL IMPLANTS 97 10 MEDICAL COATINGS MARKET, BY APPLICATION 98 10.1 INTRODUCTION 99 10.2 MEDICAL DEVICES 102 10.2.1 INCREASING DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO BOOST MARKET 102 10.3 MEDICAL IMPLANTS 102 10.3.1 ORTHOPEDIC IMPLANTS 102 10.3.1.1 Lubricity and fatigue strength in orthopedic implants 102 10.3.2 DENTAL IMPLANTS 103 10.3.2.1 Use of hydroxyapatite in dental implants to stimulate bone healing 103 10.3.3 CARDIOVASCULAR IMPLANTS 103 10.3.3.1 Nanomaterial coatings used for stents 103 10.4 MEDICAL EQUIPMENT & TOOLS 103 10.4.1 SURGICAL EQUIPMENT & TOOLS 104 10.4.1.1 Antimicrobial and other functional properties benefit surgical tools 104 10.4.2 INSTITUTIONAL EQUIPMENT 104 10.4.2.1 Hydrophobic coatings – widely used in institutional equipment 104 10.5 PROTECTIVE CLOTHING 104 10.5.1 HELPS ENHANCE HEALTHCARE SAFETY 104 10.6 OTHERS 105 11 MEDICAL COATING MARKET, BY REGION 106 11.1 INTRODUCTION 107 11.2 NORTH AMERICA 109 11.2.1 US 117 11.2.1.1 Ongoing advancements in medical technology to propel market 117 11.2.2 CANADA 120 11.2.2.1 Rising investments to boost demand for medical coatings 120   11.2.3 MEXICO 122 11.2.3.1 Rising domestic production to drive market 122 11.3 ASIA PACIFIC 125 11.3.1 CHINA 133 11.3.1.1 World’s third–largest market for medical device production 133 11.3.2 JAPAN 136 11.3.2.1 Rising percentage of geriatric population to drive market 136 11.3.3 INDIA 138 11.3.3.1 Government initiatives to fuel demand for medical coatings 138 11.3.4 SOUTH KOREA 141 11.3.4.1 Continuous R&D activities to fuel market 141 11.3.5 AUSTRALIA 143 11.3.5.1 Rising incidence of chronic diseases drive innovation in market 143 11.3.6 REST OF ASIA PACIFIC 145 11.4 EUROPE 148 11.4.1 GERMANY 157 11.4.1.1 Innovations in medical technology to drive market 157 11.4.2 UK 159 11.4.2.1 Government initiatives for collaborative developments in medical technology to drive market 159 11.4.3 FRANCE 162 11.4.3.1 Well–established medical device manufacturing industry to boost market 162 11.4.4 ITALY 164 11.4.4.1 Prevalence of chronic diseases to fuel market growth 164 11.4.5 SPAIN 167 11.4.5.1 High demand for implants and catheters to boost market 167 11.4.6 RUSSIA 169 11.4.6.1 Rising demand for minimally invasive procedures to spur market 169 11.4.7 REST OF EUROPE 171 11.5 MIDDLE EAST & AFRICA 174 11.5.1 GCC COUNTRIES 183 11.5.1.1 Saudi Arabia 183 11.5.1.1.1 Government initiatives for healthcare industry to drive market 183 11.5.1.2 UAE 186 11.5.1.2.1 Medical tourism to drive market 186 11.5.1.3 Other GCC countries 188 11.5.2 SOUTH AFRICA 191 11.5.2.1 Global investments to propel market 191 11.5.3 REST OF MIDDLE EAST & AFRICA 193   11.6 SOUTH AMERICA 196 11.6.1 BRAZIL 205 11.6.1.1 Market enhanced through local device production 205 11.6.2 ARGENTINA 207 11.6.2.1 Rising prevalence of non–communicable disease to boost market 207 11.6.3 REST OF SOUTH AMERICA 209 12 COMPETITIVE LANDSCAPE 212 12.1 OVERVIEW 212 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 213 12.3 REVENUE ANALYSIS 215 12.4 MARKET SHARE ANALYSIS 216 12.5 COMPANY VALUATION AND FINANCIAL METRICS 218 12.6 BRAND/PRODUCT COMPARISON ANALYSIS 219 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 221 12.7.1 STARS 221 12.7.2 EMERGING LEADERS 221 12.7.3 PERVASIVE PLAYERS 222 12.7.4 PARTICIPANTS 222 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 223 12.7.5.1 Company footprint 223 12.7.5.2 Region footprint 224 12.7.5.3 Coating type footprint 224 12.7.5.4 Material footprint 225 12.7.5.5 Substrate footprint 225 12.7.5.6 Application footprint 226 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 226 12.8.1 PROGRESSIVE COMPANIES 226 12.8.2 RESPONSIVE COMPANIES 226 12.8.3 DYNAMIC COMPANIES 227 12.8.4 STARTING BLOCKS 227 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 228 12.8.5.1 Detailed list of key startups/SMEs 228 12.8.5.2 Competitive benchmarking of key startups/SMEs 229 12.9 COMPETITIVE SCENARIO 231 12.9.1 PRODUCT LAUNCHES 231 12.9.2 EXPANSIONS 232 12.9.3 DEALS 233   13 COMPANY PROFILES 235 13.1 KEY PLAYERS 235 13.1.1 HYDROMER 235 13.1.1.1 Business overview 235 13.1.1.2 Products/Solutions/Services offered 235 13.1.1.3 Recent developments 236 13.1.1.3.1 Product launches 236 13.1.1.4 MnM view 237 13.1.1.4.1 Key strengths 237 13.1.1.4.2 Strategic choices 237 13.1.1.4.3 Weaknesses and competitive threats 237 13.1.2 DSM-FIRMENICH 238 13.1.2.1 Business overview 238 13.1.2.2 Products/Solutions/Services offered 239 13.1.2.3 Recent developments 240 13.1.2.3.1 Deals 240 13.1.2.4 MnM view 240 13.1.2.4.1 Key strengths 240 13.1.2.4.2 Strategic choices 240 13.1.2.4.3 Weaknesses and competitive threats 241 13.1.3 SURMODICS, INC. 242 13.1.3.1 Business overview 242 13.1.3.2 Products/Solutions/Services offered 243 13.1.3.3 Recent developments 244 13.1.3.3.1 Product launches 244 13.1.3.4 MnM view 244 13.1.3.4.1 Key strengths 244 13.1.3.4.2 Strategic choices 244 13.1.3.4.3 Weaknesses and competitive threats 245 13.1.4 BIOCOAT INCORPORATED 246 13.1.4.1 Business overview 246 13.1.4.2 Products/Solutions/Services offered 246 13.1.4.3 Recent developments 247 13.1.4.3.1 Deals 247 13.1.4.4 Expansions 247 13.1.4.4.1 Product launches 248 13.1.4.5 MnM view 248 13.1.4.5.1 Key strengths 248 13.1.4.5.2 Strategic choices 248 13.1.4.5.3 Weaknesses and competitive threats 248   13.1.5 AST PRODUCTS INC 249 13.1.5.1 Business overview 249 13.1.5.2 Products/Solutions/Services offered 249 13.1.5.3 MnM view 250 13.1.5.3.1 Key strengths 250 13.1.5.3.2 Strategic choices 250 13.1.5.3.3 Weaknesses and competitive threats 250 13.1.6 COVALON TECHNOLOGIES 251 13.1.6.1 Business overview 251 13.1.6.2 Products/Solutions/Services offered 252 13.1.6.3 MnM view 252 13.1.6.3.1 Key strengths 252 13.1.6.3.2 Strategic choices 252 13.1.6.3.3 Weaknesses and competitive threats 252 13.1.7 FREUDENBERG MEDICAL 253 13.1.7.1 Business overview 253 13.1.7.2 Products/Solutions/Services offered 254 13.1.7.3 Recent developments 255 13.1.7.3.1 Expansions 255 13.1.7.4 MnM view 255 13.1.7.4.1 Key strengths 255 13.1.7.4.2 Strategic choices 255 13.1.7.4.3 Weaknesses and competitive threats 256 13.1.8 HARLAND MEDICAL SYSTEMS, INC. 257 13.1.8.1 Business overview 257 13.1.8.2 Products/Solutions/Services offered 257 13.1.8.3 Recent developments 258 13.1.8.3.1 Expansions 258 13.1.8.4 MnM view 259 13.1.8.4.1 Key strengths 259 13.1.8.4.2 Strategic choices 259 13.1.8.4.3 Weaknesses and competitive threats 259 13.1.9 MERIT MEDICAL SYSTEMS 260 13.1.9.1 Business overview 260 13.1.9.2 Products/Solutions/Services offered 261 13.1.9.3 MnM view 262 13.1.10 APPLIED MEDICAL COATINGS 263 13.1.10.1 Business overview 263 13.1.10.2 Products/Solutions/Services offered 263 13.1.10.3 MnM view 264   13.1.11 PPG INDUSTRIES, INC 265 13.1.11.1 Business overview 265 13.1.11.2 Products/Solutions/Services offered 266 13.1.11.3 MnM view 267 13.1.11.3.1 Key strengths 267 13.1.11.3.2 Strategic choices 267 13.1.11.3.3 Weaknesses and competitive threats 267 13.1.12 THE SHERWIN-WILLIAMS COMPANY 268 13.1.12.1 Business overview 268 13.1.12.2 Products/Solutions/Services offered 269 13.1.12.3 MnM view 269 13.1.12.3.1 Key strengths 269 13.1.12.3.2 Strategic choices 270 13.1.12.3.3 Weaknesses and competitive threats 270 13.2 OTHER PLAYERS 271 13.2.1 FORMACOAT 271 13.2.2 TUA SYSTEMS 272 13.2.3 APPLIED MEMBRANE TECHNOLOGIES 273 13.2.4 A&A COATINGS 274 13.2.5 CALICO COATINGS 275 13.2.6 COATINGS2GO 276 13.2.7 CURTISS-WRIGHT CORPORATION 277 13.2.8 ENCAPSON 278 13.2.9 ENDURA COATINGS 279 13.2.10 MEDICOAT AG 280 13.2.11 MILLER-STEPHENSON CHEMICAL COMPANY, INC. 281 13.2.12 PRECISION COATING TECHNOLOGY & MANUFACTURING INC. 282 13.2.13 SPECIALTY COATING SYSTEMS 282 14 APPENDIX 283 14.1 DISCUSSION GUIDE 283 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 286 14.3 RELATED REPORTS 288 14.4 AUTHOR DETAILS 289
圖表清單 List of Tables & Figures
TABLE 1 LIST OF KEY SECONDARY SOURCES 30 TABLE 2 MEDICAL COATING MARKET: ROLE OF PLAYERS IN ECOSYSTEM 51 TABLE 3 MEDICAL COATING MARKET: PORTER’S FIVE FORCES ANALYSIS 53 TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 54 TABLE 5 KEY BUYING CRITERIA FOR TOP APPLICATIONS 55 TABLE 6 EXPORT SCENARIO FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 56 TABLE 7 IMPORT SCENARIO FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 57 TABLE 8 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2019–2023 61 TABLE 9 ANNUAL GDP PERCENTAGE CHANGE AND PROJECTION OF KEY COUNTRIES, 2024–2029 62 TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66 TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66 TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67 TABLE 13 MEDICAL COATING MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 68 TABLE 14 US ADJUSTED RECIPROCAL TARIFF RATES 73 TABLE 15 MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (USD MILLION) 79 TABLE 16 MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (USD MILLION) 80 TABLE 17 MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (KILOTONS) 80 TABLE 18 MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (KILOTONS) 80 TABLE 19 MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (USD MILLION) 86 TABLE 20 MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (USD MILLION) 86 TABLE 21 MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (KILOTONS) 87 TABLE 22 MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (KILOTONS) 87 TABLE 23 MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (USD MILLION) 93 TABLE 24 MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (USD MILLION) 94 TABLE 25 MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (KILOTONS) 94 TABLE 26 MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (KILOTONS) 94 TABLE 27 MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 100 TABLE 28 MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 100 TABLE 29 MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 101 TABLE 30 MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 101 TABLE 31 MEDICAL COATING MARKET, BY REGION, 2022–2024 (USD MILLION) 107 TABLE 32 MEDICAL COATING MARKET, BY REGION, 2025–2030 (USD MILLION) 108 TABLE 33 MEDICAL COATING MARKET, BY REGION, 2022–2024 (KILOTONS) 108 TABLE 34 MEDICAL COATING MARKET, BY REGION, 2025–2030 (KILOTONS) 108 TABLE 35 NORTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 110 TABLE 36 NORTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 110 TABLE 37 NORTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (KILOTONS) 110 TABLE 38 NORTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (KILOTONS) 110 TABLE 39 NORTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (USD MILLION) 111 TABLE 40 NORTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (USD MILLION) 111 TABLE 41 NORTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (KILOTONS) 111 TABLE 42 NORTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (KILOTONS) 112 TABLE 43 NORTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (USD MILLION) 112 TABLE 44 NORTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (USD MILLION) 113 TABLE 45 NORTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (KILOTONS) 113 TABLE 46 NORTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (KILOTONS) 114 TABLE 47 NORTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (USD MILLION) 114 TABLE 48 NORTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (USD MILLION) 115 TABLE 49 NORTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (KILOTONS) 115 TABLE 50 NORTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (KILOTONS) 115 TABLE 51 NORTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 116 TABLE 52 NORTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 116 TABLE 53 NORTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 117 TABLE 54 NORTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 117 TABLE 55 US: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 118 TABLE 56 US: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 118 TABLE 57 US: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 119 TABLE 58 US: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 119 TABLE 59 CANADA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 120 TABLE 60 CANADA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 121 TABLE 61 CANADA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 121 TABLE 62 CANADA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 122 TABLE 63 MEXICO: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 123 TABLE 64 MEXICO: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 123 TABLE 65 MEXICO: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 124 TABLE 66 MEXICO: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 124 TABLE 67 ASIA PACIFIC: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 126 TABLE 68 ASIA PACIFIC: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 126 TABLE 69 ASIA PACIFIC: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (KILOTONS) 126 TABLE 70 ASIA PACIFIC: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (KILOTONS) 127 TABLE 71 ASIA PACIFIC: MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (USD MILLION) 127 TABLE 72 ASIA PACIFIC: MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (USD MILLION) 127 TABLE 73 ASIA PACIFIC: MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (KILOTONS) 128 TABLE 74 ASIA PACIFIC: MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (KILOTONS) 128 TABLE 75 ASIA PACIFIC: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (USD MILLION) 128 TABLE 76 ASIA PACIFIC: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (USD MILLION) 129 TABLE 77 ASIA PACIFIC: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (KILOTONS) 129 TABLE 78 ASIA PACIFIC: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (KILOTONS) 130 TABLE 79 ASIA PACIFIC: MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (USD MILLION) 130 TABLE 80 ASIA PACIFIC: MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (USD MILLION) 131 TABLE 81 ASIA PACIFIC: MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (KILOTONS) 131 TABLE 82 ASIA PACIFIC: MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (KILOTONS) 131 TABLE 83 ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 132 TABLE 84 ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 132 TABLE 85 ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 133 TABLE 86 ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 133 TABLE 87 CHINA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 134 TABLE 88 CHINA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 134 TABLE 89 CHINA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 135 TABLE 90 CHINA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 135 TABLE 91 JAPAN: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 136 TABLE 92 JAPAN: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 137 TABLE 93 JAPAN: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 137 TABLE 94 JAPAN: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 138 TABLE 95 INDIA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 139 TABLE 96 INDIA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 139 TABLE 97 INDIA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 140 TABLE 98 INDIA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 140 TABLE 99 SOUTH KOREA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 141 TABLE 100 SOUTH KOREA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 142 TABLE 101 SOUTH KOREA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 142 TABLE 102 SOUTH KOREA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 143 TABLE 103 AUSTRALIA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 144 TABLE 104 AUSTRALIA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 144 TABLE 105 AUSTRALIA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 145 TABLE 106 AUSTRALIA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 145 TABLE 107 REST OF ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 146 TABLE 108 REST OF ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 146 TABLE 109 REST OF ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 147 TABLE 110 REST OF ASIA PACIFIC: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 147 TABLE 111 EUROPE: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 149 TABLE 112 EUROPE: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 149 TABLE 113 EUROPE: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (KILOTONS) 149 TABLE 114 EUROPE: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (KILOTONS) 150 TABLE 115 EUROPE: MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (USD MILLION) 150 TABLE 116 EUROPE: MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (USD MILLION) 150 TABLE 117 EUROPE: MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (KILOTONS) 151 TABLE 118 EUROPE: MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (KILOTONS) 151 TABLE 119 EUROPE: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (USD MILLION) 151 TABLE 120 EUROPE: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (USD MILLION) 152 TABLE 121 EUROPE: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (KILOTONS) 152 TABLE 122 EUROPE: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (KILOTONS) 153 TABLE 123 EUROPE: MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (USD MILLION) 153 TABLE 124 EUROPE: MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (USD MILLION) 154 TABLE 125 EUROPE: MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (KILOTONS) 154 TABLE 126 EUROPE: MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (KILOTONS) 154 TABLE 127 EUROPE: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 155 TABLE 128 EUROPE: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 155 TABLE 129 EUROPE: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 156 TABLE 130 EUROPE: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 156 TABLE 131 GERMANY: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 157 TABLE 132 GERMANY: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 158 TABLE 133 GERMANY: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 158 TABLE 134 GERMANY: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 159 TABLE 135 UK: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 160 TABLE 136 UK: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 160 TABLE 137 UK: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 161 TABLE 138 UK: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 161 TABLE 139 FRANCE: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 162 TABLE 140 FRANCE: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 163 TABLE 141 FRANCE: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 163 TABLE 142 FRANCE: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 164 TABLE 143 ITALY: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 165 TABLE 144 ITALY: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 165 TABLE 145 ITALY: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 166 TABLE 146 ITALY: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 166 TABLE 147 SPAIN: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 167 TABLE 148 SPAIN: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 168 TABLE 149 SPAIN: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 168 TABLE 150 SPAIN: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 169 TABLE 151 RUSSIA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 170 TABLE 152 RUSSIA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 170 TABLE 153 RUSSIA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 171 TABLE 154 RUSSIA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 171 TABLE 155 REST OF EUROPE: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 172 TABLE 156 REST OF EUROPE: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 172 TABLE 157 REST OF EUROPE: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 173 TABLE 158 REST OF EUROPE: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 173 TABLE 159 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 174 TABLE 160 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 174 TABLE 161 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (KILOTONS) 175 TABLE 162 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (KILOTONS) 175 TABLE 163 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (USD MILLION) 175 TABLE 164 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (USD MILLION) 176 TABLE 165 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (KILOTONS) 176 TABLE 166 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (KILOTONS) 176 TABLE 167 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (USD MILLION) 177 TABLE 168 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (USD MILLION) 177 TABLE 169 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (KILOTONS) 178 TABLE 170 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (KILOTONS) 178 TABLE 171 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (USD MILLION) 179 TABLE 172 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (USD MILLION) 179 TABLE 173 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (KILOTONS) 180 TABLE 174 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (KILOTONS) 180 TABLE 175 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 181 TABLE 176 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 181 TABLE 177 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 182 TABLE 178 MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 182 TABLE 179 SAUDI ARABIA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 184 TABLE 180 SAUDI ARABIA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 184 TABLE 181 SAUDI ARABIA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 185 TABLE 182 SAUDI ARABIA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 185 TABLE 183 UAE: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 186 TABLE 184 UAE: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 187 TABLE 185 UAE: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 187 TABLE 186 UAE: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 188 TABLE 187 OTHER GCC COUNTRIES: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 189 TABLE 188 OTHER GCC COUNTRIES: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 189 TABLE 189 OTHER GCC COUNTRIES: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 190 TABLE 190 OTHER GCC COUNTRIES: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 190 TABLE 191 SOUTH AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 191 TABLE 192 SOUTH AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 192 TABLE 193 SOUTH AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 192 TABLE 194 SOUTH AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 193 TABLE 195 REST OF MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 194 TABLE 196 REST OF MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 194 TABLE 197 REST OF MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 195 TABLE 198 REST OF MIDDLE EAST & AFRICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 195 TABLE 199 SOUTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (USD MILLION) 196 TABLE 200 SOUTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 196 TABLE 201 SOUTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY, 2022–2024 (KILOTONS) 196 TABLE 202 SOUTH AMERICA: MEDICAL COATING MARKET, BY COUNTRY, 2025–2030 (KILOTONS) 197 TABLE 203 SOUTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (USD MILLION) 197 TABLE 204 SOUTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (USD MILLION) 197 TABLE 205 SOUTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE, 2022–2024 (KILOTONS) 198 TABLE 206 SOUTH AMERICA: MEDICAL COATING MARKET, BY COATING TYPE, 2025–2030 (KILOTONS) 198 TABLE 207 SOUTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (USD MILLION) 199 TABLE 208 SOUTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (USD MILLION) 199 TABLE 209 SOUTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL, 2022–2024 (KILOTONS) 200 TABLE 210 SOUTH AMERICA: MEDICAL COATING MARKET, BY MATERIAL, 2025–2030 (KILOTONS) 200 TABLE 211 SOUTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (USD MILLION) 201 TABLE 212 SOUTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (USD MILLION) 201 TABLE 213 SOUTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE, 2022–2024 (KILOTONS) 202 TABLE 214 SOUTH AMERICA: MEDICAL COATING MARKET, BY SUBSTRATE, 2025–2030 (KILOTONS) 202 TABLE 215 SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 203 TABLE 216 SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 203 TABLE 217 SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 204 TABLE 218 SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 204 TABLE 219 BRAZIL: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 205 TABLE 220 BRAZIL: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 206 TABLE 221 BRAZIL: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 206 TABLE 222 BRAZIL: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 207 TABLE 223 ARGENTINA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 208 TABLE 224 ARGENTINA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 208 TABLE 225 ARGENTINA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 209 TABLE 226 ARGENTINA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 209 TABLE 227 REST OF SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (USD MILLION) 210 TABLE 228 REST OF SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 210 TABLE 229 REST OF SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION, 2022–2024 (KILOTONS) 211 TABLE 230 REST OF SOUTH AMERICA: MEDICAL COATING MARKET, BY APPLICATION, 2025–2030 (KILOTONS) 211 TABLE 231 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL COATING MARKET BETWEEN JANUARY 2020 AND MAY 2025 213 TABLE 232 MEDICAL COATING MARKET: DEGREE OF COMPETITION 216 TABLE 233 MEDICAL COATING MARKET: REGION FOOTPRINT 224 TABLE 234 MEDICAL COATING MARKET: COATING TYPE FOOTPRINT 224 TABLE 235 MEDICAL COATING MARKET: MATERIAL FOOTPRINT 225 TABLE 236 MEDICAL COATING MARKET: SUBSTRATE FOOTPRINT 225 TABLE 237 MEDICAL COATING MARKET: APPLICATION FOOTPRINT 226 TABLE 238 MEDICAL COATING MARKET: KEY STARTUPS/SMES 228 TABLE 239 MEDICAL COATING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/ SMES (1/2) 229 TABLE 240 MEDICAL COATING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/ SMES (2/2) 230 TABLE 241 MEDICAL COATING MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2025 231 TABLE 242 MEDICAL COATING MARKET: EXPANSIONS, JANUARY 2020–MAY 2025 232 TABLE 243 MEDICAL COATING MARKET: DEALS, JANUARY 2020–MAY 2025 233 TABLE 244 HYDROMER: COMPANY OVERVIEW 235 TABLE 245 HYDROMER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 235 TABLE 246 HYDROMER: PRODUCT LAUNCHES, JANUARY 2020–MAY 2025 236 TABLE 247 DSM-FIRMENICH: COMPANY OVERVIEW 238 TABLE 248 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 239 TABLE 249 DSM-FIRMENICH: DEALS, JANUARY 2020–MAY 2025 240 TABLE 250 SURMODICS, INC.: COMPANY OVERVIEW 242 TABLE 251 SURMODICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 243 TABLE 252 SURMODICS, INC.: PRODUCT LAUNCHES, JANUARY 2020–MAY 2025 244 TABLE 253 BIOCOAT INCORPORATED: COMPANY OVERVIEW 246 TABLE 254 BIOCOAT INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 246 TABLE 255 BIOCOAT INCORPORATED: DEALS, JANUARY 2020–MAY 2025 247 TABLE 256 BIOCOAT INCORPORATED: EXPANSIONS, JANUARY 2020–MAY 2025 247 TABLE 257 BIOCOAT INCORPORATED: PRODUCT LAUNCHES, JANUARY 2020–MAY 2025 248 TABLE 258 AST PRODUCTS INC: COMPANY OVERVIEW 249 TABLE 259 AST PRODUCTS INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 249 TABLE 260 COVALON TECHNOLOGIES: COMPANY OVERVIEW 251 TABLE 261 COVALON TECHNOLOGIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252 TABLE 262 FREUDENBERG MEDICAL: COMPANY OVERVIEW 253 TABLE 263 FREUDENBERG MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 254 TABLE 264 FREUDENBERG MEDICAL: EXPANSIONS, JANUARY 2020–MAY 2025 255 TABLE 265 HARLAND MEDICAL SYSTEMS, INC: COMPANY OVERVIEW 257 TABLE 266 HARLAND MEDICAL SYSTEMS, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 257 TABLE 267 HARLAND MEDICAL SYSTEMS, INC: EXPANSIONS, JANUARY 2020–MAY 2025 258 TABLE 268 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW 260 TABLE 269 MERIT MEDICAL SYSTEMS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 261 TABLE 270 APPLIED MEDICAL COATINGS: COMPANY OVERVIEW 263 TABLE 271 APPLIED MEDICAL COATINGS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 263 TABLE 272 PPG INDUSTRIES, INC: COMPANY OVERVIEW 265 TABLE 273 PPG INDUSTRIES, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 266 TABLE 274 THE SHERWIN-WILLIAMS COMPANY: COMPANY OVERVIEW 268 TABLE 275 THE SHERWIN-WILLIAMS COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 269 TABLE 276 FORMACOAT: COMPANY OVERVIEW 271 TABLE 277 TUA SYSTEMS: COMPANY OVERVIEW 272 TABLE 278 APPLIED MEMBRANE TECHNOLOGIES: COMPANY OVERVIEW 273 TABLE 279 A&A COATINGS: COMPANY OVERVIEW 274 TABLE 280 CALICO COATINGS: COMPANY OVERVIEW 275 TABLE 281 COATINGS2GO: COMPANY OVERVIEW 276 TABLE 282 CURTISS-WRIGHT CORPORATION: COMPANY OVERVIEW 277 TABLE 283 ENCAPSON: COMPANY OVERVIEW 278 TABLE 284 ENDURA COATINGS: COMPANY OVERVIEW 279 TABLE 285 MEDICOAT AG: COMPANY OVERVIEW 280 TABLE 286 MILLER-STEPHENSON CHEMICAL COMPANY, INC.: COMPANY OVERVIEW 281 TABLE 287 PRECISION COATING TECHNOLOGY & MANUFACTURING INC.: COMPANY OVERVIEW 282 TABLE 288 SPECIALTY COATING SYSTEMS: COMPANY OVERVIEW 282 FIGURE 1 MEDICAL COATING MARKET SEGMENTATION AND REGIONAL SCOPE 26 FIGURE 2 YEARS CONSIDERED 27 FIGURE 3 MEDICAL COATING MARKET: RESEARCH DESIGN 29 FIGURE 4 MEDICAL COATING MARKET: BOTTOM-UP APPROACH 33 FIGURE 5 MEDICAL COATING MARKET: TOP-DOWN APPROACH 33 FIGURE 6 MARKET SIZE ESTIMATION: MEDICAL COATING MARKET TOP-DOWN APPROACH 34 FIGURE 7 DEMAND-SIDE FORECAST PROJECTIONS 34 FIGURE 8 MEDICAL COATING MARKET: DATA TRIANGULATION 35 FIGURE 9 PASSIVE COATINGS TO DOMINATE MARKET 38 FIGURE 10 POLYMERS TO LEAD MARKET AMONG MATERIALS DURING FORECAST PERIOD 39 FIGURE 11 MEDICAL DEVICES TO HAVE HIGHEST CAGR DURING FORECAST PERIOD 39 FIGURE 12 NORTH AMERICA WAS LARGEST MARKET IN 2024 40 FIGURE 13 GROWING DEMAND FROM MEDICAL DEVICES TO DRIVE MARKET 41 FIGURE 14 ACTIVE COATING SEGMENT TO REGISTER HIGHER CAGR DURING FORECAST PERIOD 41 FIGURE 15 POLYMERS SEGMENT TO LEAD MARKET BY VOLUME 42 FIGURE 16 POLYMERS TO BE LARGEST SUBSTRATE SEGMENT FOR MEDICAL COATINGS 42 FIGURE 17 MEDICAL DEVICES – DOMINANT APPLICATION FOR MEDICAL COATINGS 43 FIGURE 18 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 43 FIGURE 19 MEDICAL COATING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44 FIGURE 20 MEDICAL COATING MARKET: VALUE CHAIN ANALYSIS 49 FIGURE 21 MEDICAL COATING MARKET: ECOSYSTEM 50 FIGURE 22 MEDICAL COATING MARKET: PORTER’S FIVE FORCES ANALYSIS 52 FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 54 FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 55 FIGURE 25 EXPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 56 FIGURE 26 IMPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 57 FIGURE 27 MEDICAL COATING MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 58 FIGURE 28 AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024 (USD/KG) 63 FIGURE 29 AVERAGE SELLING PRICE TREND, BY COATING TYPE, 2022–2024 (USD/KG) 64 FIGURE 30 INVESTMENT AND FUNDING SCENARIO, 2021–2024 (USD MILLION) 70 FIGURE 31 PATENTS APPLIED AND GRANTED, 2014–2024 71 FIGURE 32 LEGAL STATUS OF PATENTS (2014–2024) 72 FIGURE 33 MEDICAL COATING PATENTS: TOP JURISDICTIONS 72 FIGURE 34 PASSIVE COATINGS TO ACCOUNT FOR LARGER MARKET SHARE 79 FIGURE 35 POLYMERS TO ACCOUNT FOR LARGEST MARKET SHARE 85 FIGURE 36 METAL SUBSTRATES TO GROW FASTEST DURING FORECAST PERIOD 93 FIGURE 37 MEDICAL DEVICES SEGMENT TO DOMINATE MARKET 99 FIGURE 38 CHINA TO BE FASTEST–GROWING MARKET DURING FORECAST PERIOD 107 FIGURE 39 NORTH AMERICA: MEDICAL COATING MARKET SNAPSHOT 109 FIGURE 40 ASIA PACIFIC: MEDICAL COATING MARKET SNAPSHOT 125 FIGURE 41 EUROPE: MEDICAL COATING MARKET SNAPSHOT 148 FIGURE 42 REVENUE ANALYSIS OF TOP PLAYERS IN MEDICAL COATING MARKET, 2022–2024 215 FIGURE 43 MEDICAL COATING MARKET SHARE ANALYSIS, 2024 216 FIGURE 44 VALUATION OF LEADING COMPANIES IN MEDICAL COATING MARKET, 2024 218 FIGURE 45 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL COATING MARKET, 2024 219 FIGURE 46 MEDICAL COATING MARKET: BRAND/PRODUCT COMPARISON ANALYSIS 220 FIGURE 47 MEDICAL COATING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 222 FIGURE 48 MEDICAL COATING MARKET: COMPANY FOOTPRINT 223 FIGURE 49 MEDICAL COATING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 227 FIGURE 50 DSM-FIRMENICH: COMPANY SNAPSHOT 239 FIGURE 51 SURMODICS, INC.: COMPANY SNAPSHOT 243 FIGURE 52 COVALON TECHNOLOGIES: COMPANY SNAPSHOT 251 FIGURE 53 FREUDENBERG MEDICAL: COMPANY SNAPSHOT 254 FIGURE 54 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT 261 FIGURE 55 PPG INDUSTRIES: COMPANY SNAPSHOT 266 FIGURE 56 THE SHERWIN-WILLIAMS COMPANY: COMPANY SNAPSHOT 269

同分類最新報告（化學與材料）

查看化學與材料全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們